FDA Clears Roche’s PCR-Based MRSA Nasal Test
July 15, 2010
FDA Clears Roche’s PCR-Based MRSA Nasal Test
Roche's test becomes the second PCR-based MRSA test approved for clinical use in the US, joining Cepheid's Xpert MRSA/SA nasal assay for the GeneXpert PCR platform.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Roche, Cepheid Execs Wrangle over Clinical Market for PCR-based MRSA Tests
July 29, 2010 / PCR Insider - Cepheid Highlights Strong Uptake of Xpert CT/NG as Q1 Revenues Rise 19 Percent
April 25, 2013 / PCR Insider - Cepheid Recalls MRSA Blood Culture Test for Second Time; Company, Analysts Unconcerned
January 12, 2012 / PCR Insider - More Trouble for Cepheid MRSA Test as Abaxis Sues for Patent Infringement
July 15, 2010 / PCR Insider - On Heels of FDA Approval, Cepheid's Xpert CT/NG Test Performs Well in Multi-Center Clinical Study
March 14, 2013 / PCR Insider